These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25863911)

  • 1. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
    Bortolasci CC; Vargas HO; Vargas Nunes SO; de Melo LG; de Castro MR; Moreira EG; Dodd S; Barbosa DS; Berk M; Maes M
    J Affect Disord; 2015 Jul; 179():148-55. PubMed ID: 25863911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder.
    Nunes SO; Piccoli de Melo LG; Pizzo de Castro MR; Barbosa DS; Vargas HO; Berk M; Maes M
    J Affect Disord; 2015 Feb; 172():55-62. PubMed ID: 25451396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
    Landucci Bonifácio K; Sabbatini Barbosa D; Gastaldello Moreira E; de Farias CC; Higachi L; Camargo AEI; Favaro Soares J; Odebrecht Vargas H; Nunes SOV; Berk M; Dodd S; Maes M
    J Affect Disord; 2017 Nov; 222():185-194. PubMed ID: 28710952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid.
    Oliveira SR; Kallaur AP; Lopes J; Colado Simão AN; Reiche EM; de Almeida ERD; Morimoto HK; de Carvalho Jennings de Pereira WL; Alfieri DF; Flauzino T; de Meleck Proença C; Gomes AM; Kaimen-Maciel DR; Maes M
    Psychiatry Res; 2017 Apr; 250():113-120. PubMed ID: 28152396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased nitro-oxidative toxicity in association with metabolic syndrome, atherogenicity and insulin resistance in patients with affective disorders.
    Morelli NR; Maes M; Bonifacio KL; Vargas HO; Nunes SOV; Barbosa DS
    J Affect Disord; 2021 Nov; 294():410-419. PubMed ID: 34320448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
    Venturini D; Simão AN; Dichi I
    Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders.
    Vargas HO; Nunes SO; Barbosa DS; Vargas MM; Cestari A; Dodd S; Venugopal K; Maes M; Berk M
    Life Sci; 2014 Apr; 102(1):65-71. PubMed ID: 24607777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome.
    Ebron K; Andersen CJ; Aguilar D; Blesso CN; Barona J; Dugan CE; Jones JL; Al-Sarraj T; Fernandez ML
    Metab Syndr Relat Disord; 2015 Dec; 13(10):458-64. PubMed ID: 26431271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
    Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
    Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database.
    Bonora E; Capaldo B; Perin PC; Del Prato S; De Mattia G; Frittitta L; Frontoni S; Leonetti F; Luzi L; Marchesini G; Marini MA; Natali A; Paolisso G; Piatti PM; Pujia A; Solini A; Vettor R; Bonadonna RC;
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):624-31. PubMed ID: 18060751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
    Meshkani R; Zargari M; Larijani B
    Acta Diabetol; 2011 Mar; 48(1):79-88. PubMed ID: 21046418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China.
    Chen D; Zhang H; Gao Y; Lu Z; Yao Z; Jiang Y; Lin X; Wu C; Yang X; Tan A; Mo Z
    Clin Chim Acta; 2015 Jun; 446():226-30. PubMed ID: 25913163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and metabolic syndrome in obese and non-obese children.
    Moreno LA; Pineda I; Rodríguez G; Fleta J; Giner A; Juste MG; Sarría A; Bueno M
    Horm Metab Res; 2002 Jul; 34(7):394-9. PubMed ID: 12189588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.
    Bonora E; Targher G; Zenere MB; Saggiani F; Cacciatori V; Tosi F; Travia D; Zenti MG; Branzi P; Santi L; Muggeo M
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):975-80. PubMed ID: 8923153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
    Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.
    Rajaie S; Azadbakht L; Khazaei M; Sherbafchi M; Esmaillzadeh A
    Nutrition; 2014 Jan; 30(1):61-8. PubMed ID: 24290600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
    Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
    Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal uric acid threshold to identify insulin resistance in healthy women.
    Salazar MR; Espeche WG; March CE; Marillet AG; Balbín E; Dulbecco CA; Carbajal HA
    Metab Syndr Relat Disord; 2012 Feb; 10(1):39-46. PubMed ID: 21933003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.